Effectiveness of a Ketogenic Diet in Children With Refractory Epilepsy: A Systemic Review

Authors

  • Jahnavi Gurramkonda M.D. California Institute of Behavioral Neurosciences & Psychology 4751 Mangels Blvd Fairfield CA US ,
  • Shaan I. Chaudhr Lahore Medical and Dental College, Lahore, Punjab, PK ,
  • Amina Amin MBBS Shifa International Hospitals Ltd, Islamabad, Islamabad, PK ,
  • Binay K. Panjiyar M.D. Harvard Medical School, Boston, MA, US ,
  • Dhuha S. Al-taie California Institute of Behavioral Neurosciences & Psychology, Fairfield, CA, USA ,
  • Esraa M. AlEdani M.D University of Basrah,Basrah, Basra, IQ ,
  • Lubna Mohammed California Institute of Behavioral Neurosciences & Psychology, Fairfield CA USA ,

DOI:

https://doi.org/10.56570/jimgs.v3i2.169

Keywords:

Refractory epilepsy, Ketogenic diet, Children (pediatrics), Seizure reduction, Systematic review (PRISMA)

Abstract

A notable proportion (10%-20%) of children with epilepsy remain unresponsive to pharmacological treatment. Current strategies for the management of refractory epilepsy encompass surgical treatments (vagus nerve stimulation) as well as the adoption of a Ketogenic Diet. By adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, we conducted a systematic review to identify all relevant studies in English language that investigated the effectiveness of a Ketogenic diet in children with refractory epilepsy. A total of 125 studies were identified and eight, involving a total of 1330 patients, met the criteria. Of the identified eight studies, one was randomized controlled trial, one was systematic review/meta-analysis, and the rest were observational studies. More than half (54%) of the participants reported seizure resolution, while 17% became seizure-free after one month of initiating the ketogenic diet. Ketogenic diet have been shown to be efficacious for the treatment of epilepsy in infants.

References

Titre-Johnson S, Schoeler N, Eltze C, Williams R: Ketogenic diet in the treatment of epilepsy in children under the age of 2 years: Study protocol for a randomised controlled trial. Trials. 2017, 18:195. 10.1186/s13063-017-1918-3

Fiest KM, Sauro KM, Wiebe S: Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017, 88:296-303. 10.1212/WNL.0000000000003509

Hauser WA, Annegers JF, Kurland LT: Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia. 1993, 34:453-68. 10.1111/j.1528-1157.1993.tb02586.x

Kwan P, Schachter SC, Brodie MJ: Drug-resistant epilepsy. N. Engl. J. Med. 2011, 365:919-926. 10.1056/NEJMra1004418

Udani VP, Dharnidharka V, Nair A: Difficult to control epilepsy in childhood-A long-term study of 123 cases. Indian Pediatr. 1993, 30:1199-206.

Puchalska P, Crawford PA: Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab. 2017, 25:262-284. 10.1016/j.cmet.2016.12.022

Cahill GF: Fuel metabolism in starvation. Annu. Rev. Nutr. 2006, 26:1-22. 10.1146/annurev.nutr.26.061505.111258

McGarry JD, Foster DW: Regulation of hepatic fatty acid oxidation and ketone body production. Annu. Rev. Biochem. 1980, 49:395-420. 10.1146/annurev.bi.49.070180.002143

Robinson AM, Williamson DH: Physiological roles of ketone bodies as substrates and signals in mammaliantissues. Physiol. Rev. 1980, 60:143-187. 10.1152/physrev.1980.60.1.143

Aneja P, Dziak R, Cai GQ, Charles TC: Identification of an acetoacetyl coenzyme A synthetase-dependentpathway for utilization of L-(+)-3-hydroxybutyrate in Sinorhizobium meliloti. J. Bacteriol. 2002, 184:1571-1577. 10.1128/JB.184.6.1571-1577.2002

Krishnakumar AM, Sliwa D, Endrizzi JA: Getting a handle on therole of coenzyme M in alkene metabolism. Microbiol. Mol. Biol. Rev. 2008, 72:445-45. 10.1128/MMBR.00005-08

Yang H, Shan W, Zhu F: Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms. Front. Neurol. 2019, 10:585. 10.3389/fneur.2019.00585

Wheless JW: History of the ketogenic diet. Epilepsia. 2008, 49:3-5. 10.1111/j.1528-1167.2008.01821.x

Peterman MG: The Ketogenic Diet. JAMA. 1928, 90:1427-1429. 10.1001/jama.1925.02660520007003

Woodyatt RT: Objects and Method of Diet Adjustment in Diabetes. JAMA Intern. Med. 1921, 28:125-141. 10.1001/archinte.1921.00100140002001

Wilder R: The effect on ketonemia on the course of epilepsy. Mayo Clin. Proc.1921. 2:307-308.

Vining EP, Freeman JM, Ballaban-Gil K: A multicenter study of the efficacy of the ketogenic diet. Arch. Neurol. 1998, 55:1433-1437. 10.1001/archneur.55.11.1433

Kossoff EH, Zupec-Kania BA, Rho JM: Ketogenic diets: An update for child neurologists. J Child Neurol. 2009, 24:979-88. 10.1177/0883073809337162

Page MJ, McKenzie JE, Bossuyt PM: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:71. 10.1136/bmj.n71

El-Shafie AM, Bahbah WA, Abd El Naby SA. Impact of two ketogenic diet types in refractory childhood epilepsy. Pediatr Res. 2023112. 10.1038/s41390-023-02554-w

Ruiz-Herrero J, Cañedo-Villarroya E, Pérez-Sebastián I: Efficacy and safety of ketogenic dietary theraphies in infancy. A single-center experience in 42 infants less than two years of age. Seizure. 2021, 92:106-111. 10.1016/j.seizure.2021.08.018

Yang R, Wen J, Wei W, Chen H: Improving the effects of ketogenic diet therapy in children with drug-resistant epilepsy. Seizure. 2022, 94:183-188. 10.1016/j.seizure.2021.10.021

Israel RA, Elizabeth PM: Description and evaluation of the effects of the cetogenic diet in children with refractory epilepsy. J. Selva Andina Res. Soc. 2020, 11:142-152. 10.36610/j.jsars.2020.110200142x

Rebollo G, María J, Díaz SM: Ketogenic Diet in patients with refractory epilepsy. Rev. chil. pediatr. 2020, 91:697-704. 10.32641/rchped.vi91i5.1563

Gürbüz G, Kumru B, Özsevik S: The Efficacy, Safety and Side-Effect Profile of the Ketogenic Diet in the Treatment of Pediatric Super-Refractory Status Epilepticus. J Nutri Med Diet Care. 2019, 5:041. 10.23937/2572-3278.1510041

Ismayilova N, Leung M, Kumar R: Ketogenic diet therapy in infants less than two years of age for medically refractory epilepsy. Seizure. 2018:5-7. 10.1016/j.seizure.2018.02.014

Lyons L, Schoeler NE, Langan D: Use of ketogenic diet therapy in infants with epilepsy: A systematic review and meta-analysis. Epilepsia. 2020, 61:1261-1281. 10.1111/epi.16543

Van der Louw E, van den Hurk D, Neal E: Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol. 2016, 20:798-809. 10.1016/j.ejpn.2016.07.009

Dressler A, Trimmel-Schwahofer P: The ketogenic diet for infants: how long can you go?. Epilepsy Res. 2020, 164106339:10.1016/j.eplepsyres.2020.106339

Nordli DR, Kuroda MM, Carroll J: Experience With the Ketogenic Diet in Infants. Pediatrics. 2001, 108:129-133. 10.1542/peds.108.1.129

Pires, Maria E, Ilea A: Ketogenic Diet for Infantile Spasms Refractory to First-line Treatments: An Open Prospective Study. Epilepsy Research. 2013, 105:189-194. 10.1016/j.eplepsyres.2012.11.009

Kayyali HR, Gustafson M, Myers T: Ketogenic diet efficacy in the treatment of intractable epileptic spasms. Pediatr Neurol. 2014, 50:224-227. 10.1016/j.pediatrneurol.2013.11.021

Ruiz Herrero J: Safety and effectiveness of the prolonged treatment of children with a ketogenic diet. Nutrients. 2020, 12:306. 10.3390/nu12020306

Rezaei S, Abdurahman AA, Saghazadeh A: Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: a systematic review and meta-analysis. Nutr Neurosci. 2019, 22:317-334. 10.1080/1028415X.2017.1387721

Sondhi V, Agarwala A, Pandey RM: Efficacy of ketogenic diet, modified atkins diet, and low glycemic index therapy diet among children with drug-resistant epilepsy: a randomized clinical trial. JAMA Pediatr. 2020, 174:944-951. 10.1001/jamapediatrics.2020.2282

Caraballo RH: Ketogenic diet in patients with myoclonic-astatic epilepsy. Epileptic Disord. 2006:151-155.

Korff C: Dravet syndrome (severe myoclonic epilepsy in infancy): a retrospective study of 16 patients. J. Child Neurol. 2007, 22:185-194. 10.1177/0883073807300294

Kilaru S. & Bergqvist AGC: Current treatment of myoclonic astatic epilepsy: clinical experience at the Children’s Hospital of Philadelphia. Epilepsia. 2007, 48:1703-1707. 10.1111/j.1528-1167.2007.01186.x

Falsaperla R, D'Angelo G, Praticò AD. Ketogenic diet for infants with epilepsy: a literature review. Epilepsy Behav. 2020112107361. 10.1016/j.yebeh.2020.107361

Kossoff, Eric H, Beth A: Optimal Clinical Management of Children Receiving Dietary Therapies for Epilepsy: Updated Recommendations of the International Ketogenic Diet Study Group. Epilepsia. 2018, 3:175-192. 10.1002/epi4.12225

Cai QY, Zhou ZJ, Luo R: Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017, 13:528-536. 10.1007/s12519-017-0053-2

Jagadish S, Payne ET, Wong-Kisiel L: The Ketogenic and Modified Atkins Diet Therapy for Children With Refractory Epilepsy of Genetic Etiology. Pediatr Neurol. 2019, 94:32-37. 10.1016/j.pediatrneurol.2018.12.012

Ye F, Li XJ, Jiang WL, Sun HB: Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol. 2015, 11:26-31. 10.3988/jcn.2015.11.1.26

Neal EG, Chaffe H, Schwartz RH: The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. The. Lancet Neurol. 2008, 7:500-506. 10.1016/S1474-4422(08)70092-9

Pasca L, De Giorgis V, Macasaet JA: The changing face of dietary therapy for epilepsy. Eur J Pediatr. 2016, 175:1267-1276. 10.1007/s00431-016-2765-z

Kossoff EH, Rowley H, Sinha SR: A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 2008, 49:316-319. 10.1111/j.1528-1167.2007.01256.x

Martin K, Jackson CF, LevyRG : Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst. Rev. 2016, 2:001903. 10.1002/14651858.CD001903.pub3

Kim DW, Kang HC, Park JC : Benefits of the nonfasting ketogenic diet compared with the initial fasting ketogenic diet. Pediatrics. 2004, 114:1627-1630. 10.1542/peds.2004-1001

Pietrzak D, Kasperek K, Rękawek P : The therapeutic role of ketogenic diet in neurological

Coppola G: Ketogenic diet for the treatment of catastrophic epileptic encephalopathies in childhood. Eur. J. Paediatr. Neurol. 2010, 14:229-234. 10.1016/j.ejpn.2009.06.006

Kossoff EH, McGrogan JR, Bluml RM: A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006, 47:421-4. 10.1111/j.1528-1167.2006.00438.x

Güzel O, Yılmaz U, Uysal U : The effect of olive oil-based ketogenic diet on serum lipid levels in epileptic children. Neurol. Sci. 2016, 37:465-470. 10.1007/s10072-015-2436-2

Liu, Hongyan, Yang Y, Wang Y: Ketogenic Diet for Treatment of Intractable Epilepsy in Adults: A Meta-analysis of Observational Studies. Epilepsia. 2018, 3:9-17. 10.1002/epi4.12098

Kim JA, Yoon JR, Lee EJ: Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia. 2016, 57:51-58. 10.1111/epi.13256

Ferraris C: Impact of the ketogenic diet on linear growth in children: a single-center retrospective analysis of 34 cases. Nutrients. 2019, 11:1442. 10.3390/nu11071442

Svedlund A, Hallböök T, Magnusson P: Prospective study of growth and bone mass in Swedish children treated with the modified Atkins diet. Eur. J. Paediatr. Neurol. 2019, 23:629-638. 10.1016/j.ejpn.2019.04.001

Groleau V, Schall JI, Stallings VA: Long-term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy. Dev Med Child Neurol. 2014, 56:898-904. 10.1111/dmcn.12462

Downloads

Published

2024-09-11

How to Cite

1.
Gurramkonda J, Chaudhr SI, Amin A, et al. Effectiveness of a Ketogenic Diet in Children With Refractory Epilepsy: A Systemic Review. Journal For International Medical Graduates. 2024;3(2). doi:10.56570/jimgs.v3i2.169